Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients
Clinical trial NCT05529069 · RECRUITING
Trial details
- NCT number
- NCT05529069
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-25
- Primary completion
- 2027-04-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.